<<

Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices 56633

Controlled substance Drug code Schedule

Beta-hydroxyfentanyl ...... 9830 I Beta-hydroxy-3-methylfentanyl ...... 9831 I Alpha-methylthiofentanyl ...... 9832 I 3-Methylthiofentanyl ...... 9833 I ...... 9835 I related-substances as defined in 21 CFR 1308.11(h) ...... 9850 I ...... 1105 II ...... 1724 II Amobarbital ...... 2125 II ...... 2270 II Secobarbital ...... 2315 II ...... 2550 II ...... 7379 II 1-Phenylcyclohexylamine ...... 7460 II ...... 7471 II Phenylacetone ...... 8501 II 1-Piperidinocyclohexanecarbonitrile ...... 8603 II Alphaprodine ...... 9010 II ...... 9120 II Ecgonine ...... 9180 II ...... 9190 II ...... 9210 II ...... 9220 II Meperidine ...... 9230 II , bulk (non-dosage forms) ...... 9273 II Levo- ...... 9648 II ...... 9668 II Racemethorphan ...... 9732 II ...... 9737 II ...... 9739 II ...... 9740 II ...... 9743 II ...... 9780 II

The company plans to import the substance(s). Refer to Supplemental distribution to its customers. No other listed controlled substances for the Information listed below for further activity for this drug code is authorized manufacturing of analytical reference drug information. for this registration. standards and distribution to their DATES: Registered bulk manufacturers of William T. McDermott, research and forensic customers. the affected basic class(es), and Assistant Administrator. Approval of permit application will applicants therefore, may file written occur only when the registrant’s activity comments on or objections to the [FR Doc. 2020–20162 Filed 9–11–20; 8:45 am] is consistent with what is authorized issuance of the proposed registration on BILLING CODE P under 21 U.S.C. 952(a)(2). Authorization or before November 13, 2020 Such will not extend to the import of Food persons may also file a written request DEPARTMENT OF JUSTICE and Drug Administration-approved or for a hearing on the application on or non-approved finished dosage forms for before November 13, 2020. Drug Enforcement Administration commercial sale. ADDRESSES: Written comments should [Docket No. DEA–709] William T. McDermott, be sent to: Drug Enforcement Assistant Administrator. Administration, Attention: DEA Federal Bulk Manufacturer of Controlled [FR Doc. 2020–20159 Filed 9–11–20; 8:45 am] Register Representative/DPW, 8701 Substances Application: Cambridge Morrissette Drive, Springfield, Virginia BILLING CODE P Isotype Lab 22152. AGENCY: Drug Enforcement SUPPLEMENTARY INFORMATION: In Administration, Justice. DEPARTMENT OF JUSTICE accordance with 21 CFR 1301.33(a), this is notice that on August 5, 2020, ACTION: Notice of application. Drug Enforcement Administration Organix Inc., 240 Salem Street, Woburn, SUMMARY: Cambridge Isotype Lab has [Docket No. DEA–712] Massachusetts 01801–2029, applied to applied to be registered as a bulk be registered as a bulk manufacturer of manufacturer of basic class(es) of Bulk Manufacturer of Controlled the following basic class(es) of a controlled substance(s). Refer to Substances Application: Organix Inc. controlled substance(s): Supplemental Information listed below for further drug(s) information. AGENCY: Drug Enforcement Controlled substance Drug code Schedule Administration, Justice. DATES: Registered bulk manufacturers of ACTION: Notice of application. 5-Methoxy-N-N- 7431 I the affected basic class(es), and dimethyltryptamine. applicants therefore, may file written SUMMARY: Organix Inc. has applied to be comments on or objections to the registered as a bulk manufacturer of The company plans to synthesize the issuance of the proposed registration on basic class(es) of controlled above-listed controlled substance for or before November 13, 2020. Such

VerDate Sep<11>2014 17:51 Sep 11, 2020 Jkt 250001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 E:\FR\FM\14SEN1.SGM 14SEN1 khammond on DSKJM1Z7X2PROD with NOTICES